One Health-based control strategies for MERS-CoV

One Health-based control strategies for MERS-CoV

Bibliographic Details
Main Author:	M. Hemida
Format:	Article
Language:	English
Published:	Elsevier 2020-02-01
Series:	Journal of Infection and Public Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034120301854

Similar Items

MERS-CoV
by: Beuy Joob, et al.
Published: (2014-09-01)

MERS-CoV
Published: (2019)

Lack of detection of the Middle East respiratory syndrome coronavirus (MERS-CoV) nucleic acids in some Hyalomma dromedarii infesting some Camelu dromedary naturally infected with MERS-CoV
by: Maged Gomaa Hemida, et al.
Published: (2021-03-01)

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
by: Chantal B.E.M. Reusken, et al.
Published: (2016-06-01)

The SARS-CoV-2 outbreak from a one health perspective
by: Maged Gomaa Hemida, et al.
Published: (2020-12-01)

MERS-CoV: An Emerging Public Health Threat
by: R Danasekaran, et al.
Published: (2014-01-01)

NeoCoV Is Closer to MERS-CoV than SARS-CoV
by: Mohamed M Hassan, et al.
Published: (2020-06-01)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
by: Ayman Mubarak, et al.
Published: (2019-01-01)

MERS-CoV diagnosis: An update
by: Sameera Al Johani, et al.
Published: (2016-05-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
by: David L. Suarez, et al.
Published: (2020-12-01)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020-10-01)

MERS CoV infection - ecological investigations
by: S.F. Fagbo, et al.
Published: (2014-04-01)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
by: Karima A. Al-Salihi, et al.
Published: (2021-01-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

MERS-CoV: Bridging the Knowledge Gaps
by: Abdullah Balkhair, et al.
Published: (2014-05-01)

Drivers of MERS-CoV Emergence in Qatar
by: Elmoubasher Farag, et al.
Published: (2018-12-01)

Survey on Implementation of One Health Approach for MERS-CoV Preparedness and Control in Gulf Cooperation Council and Middle East Countries
by: Elmoubasher Abu Baker Farag, et al.
Published: (2019-03-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Phylogenetic Analysis of MERS-CoV in a Camel Abattoir, Saudi Arabia, 2016–2018
by: Maged Gomaa Hemida, et al.
Published: (2020-12-01)

Protein Intrinsic Disorder and Evolvability of MERS-CoV
by: Vladimir N. Uversky, et al.
Published: (2021-04-01)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV.
by: Priya V K, et al.
Published: (2021-01-01)

MERS-CoV spillover at the camel-human interface
by: Gytis Dudas, et al.
Published: (2018-01-01)

Host Determinants of MERS-CoV Transmission and Pathogenesis
by: W. Widagdo, et al.
Published: (2019-03-01)

Development of Small-Molecule MERS-CoV Inhibitors
by: Ruiying Liang, et al.
Published: (2018-12-01)

The Struggle Against MERS-CoV (The Novel Coronavirus)
by: Abdullah Balkhair, et al.
Published: (2013-07-01)

Domestic Pig Unlikely Reservoir for MERS-CoV
by: Emmie de Wit, et al.
Published: (2017-06-01)

Co-infection of MERS-CoV and SARS-CoV-2 in the same host: A silent threat
by: Buket Baddal, et al.
Published: (2020-09-01)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
by: João Trigueiro-Louro, et al.
Published: (2020-01-01)

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
by: Sultan Nafea Alharbi, et al.
Published: (2021-03-01)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
by: Mitsuru Sada, et al.
Published: (2020-10-01)

Convalescent plasma as a therapeutic agent for SARS-CoV, MERS-CoV and SARS-CoV-2: A scoping review
by: Abeba Haile Mariamenatu, et al.
Published: (2021-01-01)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
by: Stacey L. P. Scroggs, et al.
Published: (2021-12-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

MERS-CoV Antibodies in Humans, Africa, 2013–2014
by: Anne M. Liljander, et al.
Published: (2016-06-01)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
by: Yanwen Liang, et al.
Published: (2020-05-01)